A Phase III Randomized, Open-Label Study of Optune Ttfields, 200KHZ Concomitant with Radiation Therapy and Temozolomide for the Treatment of Newly Diagnosed Glioblastoma

Brief Summary

Type:
Brain Tumors / Neurologic Cancers

Study Type:
Treatment

Phase:
III

ClinicalTrials.gov Identifier:
NCT04471844

Study #:
STUDY00146758

Start Date:
Apr 13, 2022

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT04471844

View Complete Trial Details & Eligibility at ClinicalTrials.gov